SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 101 filers reported holding SPERO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,420 | -16.6% | 2,000 | 0.0% | 0.00% | – |
| Q2 2023 | $2,900 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2,900 | -16.2% | 2,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3,460 | -13.5% | 2,000 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +300.0% | 2,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -88.9% | 2,000 | +100.0% | 0.00% | – |
| Q1 2022 | $9,000 | -43.8% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | -11.1% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | +28.6% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $14,000 | -6.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2021 | $15,000 | -21.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2020 | $19,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,829,209 | $53,456,000 | 13.89% |
| Atlas Venture Associates IX, LLC | 1,376,968 | $19,223,000 | 3.38% |
| BVF INC/IL | 2,137,978 | $29,846,000 | 1.12% |
| AWM Investment Company, Inc. | 372,755 | $5,204,000 | 0.51% |
| Novo Holdings A/S | 468,902 | $6,546,000 | 0.29% |
| Rock Springs Capital Management LP | 965,928 | $13,484,000 | 0.27% |
| Alphabet Inc. | 889,979 | $12,424,000 | 0.25% |
| Artal Group S.A. | 500,000 | $6,980,000 | 0.14% |
| Granahan Investment Management | 332,639 | $4,644,000 | 0.09% |
| Radnor Capital Management, LLC | 10,000 | $140,000 | 0.05% |